Softwr

Research · head to head

Genedata vs Sapio Sciences

Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-
Full reviewWebsite
Sapio Sciences logo

Sapio Sciences

Research

Science-aware laboratory platform combining LIMS, ELN and scientific data management

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.; Sapio Sciences smaller vendor than the enterprise incumbents, which conservative laboratory procurement weights heavily for a system that must last a decade
  • They diverge on capability: Genedata covers Screener, Sapio Sciences covers Unified LIMS and ELN.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Genedata and Sapio Sciences actually diverge.

Attributes where Genedata and Sapio Sciences differ
AttributeGenedataSapio Sciences
PlatformsWeb, On-premise, Private cloudWeb, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

Only in Sapio Sciences

  • Unified LIMS and ELN
  • No-code configuration
  • Scientific data management
  • Science-aware data model
  • Analysis tools
  • Regulated support

What people use each for

The jobs each tool is most often brought in to do.

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot Sapio Sciences
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot Sapio Sciences
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot Sapio Sciences
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot Sapio Sciences

Sapio Sciences

  • Laboratories whose workflows change often enough that vendor change requests become the bottlenecknot Genedata
  • Biotech organisations needing LIMS and ELN on one data modelnot Genedata
  • Research groups wanting scientific staff to own configuration rather than ITnot Genedata
  • Organisations replacing a rigid legacy LIMS they can no longer adaptnot Genedata

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

Sapio Sciences

  • Smaller vendor than the enterprise incumbents, which conservative laboratory procurement weights heavily for a system that must last a decade
  • Pricing is not published, so early comparison requires a sales process
  • No-code configuration still requires someone with the time and inclination to learn it, and laboratories that assign nobody end up where they started
  • Smaller partner ecosystem and fewer independent implementation resources
  • Less accumulated regulatory validation precedent than LabWare, which matters for inspected pharmaceutical QC

Pricing, plan by plan

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

Sapio Sciences

On request
  • Sapio Platform$undefined/year
    • LIMS
    • ELN
    • Scientific data management

Which should you pick?

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.
Genedata review

Choose Sapio Sciences if

  • You need unified lims and eln.
  • You work on Web, Cloud, On-premise.
  • You also want no-code configuration.
Sapio Sciences review

Questions people ask

Is Genedata or Sapio Sciences better?
Neither clearly leads. Genedata starts at On request and Sapio Sciences at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Genedata or Sapio Sciences?
Genedata starts at On request and Sapio Sciences at On request.
Does Genedata or Sapio Sciences run on more platforms?
Genedata runs on Web, On-premise, Private cloud. Sapio Sciences runs on Web, Cloud, On-premise.
What is Genedata best used for?
Genedata is most often used for a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale, a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets, a process development group standardising bioprocess run data across sites for modelling and scale-up, a cro delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelines. Of those, a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale and a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets are not what Sapio Sciences is typically brought in for.
What can Genedata do that Sapio Sciences cannot?
Genedata covers Screener, Biologics, Bioprocess, Expressionist. Sapio Sciences covers Unified LIMS and ELN, No-code configuration, Scientific data management, Science-aware data model.

Answered from the vendors’ own pages

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

Sapio Sciences: What is the no-code claim actually about?

Changing workflows, data models and screens without a vendor services engagement. The problem it targets is real: most LIMS are configured once at implementation and every later change becomes a costly change request.

Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

Sapio Sciences: Does no-code mean no effort?

No. Someone in the laboratory has to learn the configuration model and own it. Laboratories that assign nobody end up with the same rigidity they were escaping.

Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

Sapio Sciences: What does it cost?

Not published. Annual enterprise licensing quoted on users and modules.

Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

Sapio Sciences: Is it suitable for regulated QC?

It supports regulated environments, but LabWare and STARLIMS have far more accumulated validation precedent. For inspected pharmaceutical QC that history carries real weight.

Sapio Sciences: How does it compare to Benchling?

Both are modern and science-aware. Benchling is stronger in research molecular biology; Sapio positions more toward configurable LIMS and ELN across research and regulated work.

Share

Related pages

More on Genedata

More on Sapio Sciences

Keep looking

Other head to heads